First CLTI patient enrolled in PROMISE II pivotal study of LimFlow system - Vascular News

First CLTI patient enrolled in PROMISE II pivotal study of LimFlow system  Vascular News

Comments

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management